#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1645699	Functional	Antiproliferative activity against EGFR-deficient human PC9 cells	Homo sapiens	39	ALA1641501	cell-based format	Scientific Literature
2.	ALA1645700	Functional	Antiproliferative activity against growth-resistant human PC9 cells expressing EGFR E746_A750/T790M mutant	Homo sapiens	40	ALA1641501	cell-based format	Scientific Literature
3.	ALA2363477	Functional	SANGER: Inhibition of human NCI-H1581 cell growth in a cell viability assay.	Homo sapiens	137	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
4.	ALA2363480	Functional	SANGER: Inhibition of human NCI-H1648 cell growth in a cell viability assay.	Homo sapiens	133	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
5.	ALA2363481	Functional	SANGER: Inhibition of human NCI-H1650 cell growth in a cell viability assay.	Homo sapiens	134	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
6.	ALA2363485	Functional	SANGER: Inhibition of human NCI-H1694 cell growth in a cell viability assay.	Homo sapiens	77	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
7.	ALA2363489	Functional	SANGER: Inhibition of human NCI-H1770 cell growth in a cell viability assay.	Homo sapiens	129	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
8.	ALA2363492	Functional	SANGER: Inhibition of human NCI-H1838 cell growth in a cell viability assay.	Homo sapiens	134	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
9.	ALA2363493	Functional	SANGER: Inhibition of human NCI-H187 cell growth in a cell viability assay.	Homo sapiens	77	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
10.	ALA2363494	Functional	SANGER: Inhibition of human NCI-H1882 cell growth in a cell viability assay.	Homo sapiens	77	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
11.	ALA2363495	Functional	SANGER: Inhibition of human NCI-H1963 cell growth in a cell viability assay.	Homo sapiens	77	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
12.	ALA2363502	Functional	SANGER: Inhibition of human NCI-H2081 cell growth in a cell viability assay.	Homo sapiens	77	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
13.	ALA2363504	Functional	SANGER: Inhibition of human NCI-H209 cell growth in a cell viability assay.	Homo sapiens	125	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
14.	ALA2363505	Functional	SANGER: Inhibition of human NCI-H2107 cell growth in a cell viability assay.	Homo sapiens	31	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
15.	ALA2363507	Functional	SANGER: Inhibition of human NCI-H2126 cell growth in a cell viability assay.	Homo sapiens	134	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
16.	ALA2363508	Functional	SANGER: Inhibition of human NCI-H2141 cell growth in a cell viability assay.	Homo sapiens	77	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
17.	ALA2363510	Functional	SANGER: Inhibition of human NCI-H2171 cell growth in a cell viability assay.	Homo sapiens	77	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
18.	ALA2363511	Functional	SANGER: Inhibition of human NCI-H2196 cell growth in a cell viability assay.	Homo sapiens	77	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
19.	ALA2363514	Functional	SANGER: Inhibition of human NCI-H226 cell growth in a cell viability assay.	Homo sapiens	137	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer
20.	ALA2363516	Functional	SANGER: Inhibition of human NCI-H23 cell growth in a cell viability assay.	Homo sapiens	137	ALA1201861	cell-based format	Sanger Institute Genomics of Drug Sensitivity in Cancer